Cutting Edge: CD95 Maintains Effector T Cell Homeostasis in Chronic Immune Activation
Author(s) -
Ramon Arens,
Paul A. Baars,
Margot Jak,
Kiki Tesselaar,
Martin van der Valk,
Marinus H. J. van Oers,
René A. W. van Lier
Publication year - 2005
Publication title -
the journal of immunology
Language(s) - English
Resource type - Journals
eISSN - 1550-6606
pISSN - 0022-1767
DOI - 10.4049/jimmunol.174.10.5915
Subject(s) - fas receptor , effector , biology , microbiology and biotechnology , immune system , homeostasis , immunology , apoptosis , cancer research , programmed cell death , biochemistry
The elimination of activated T cells is important to maintain homeostasis and avoid immunopathology. CD95 (Fas/APO-1) has been identified as a death mediator for activated T cells in vitro but the function of CD95 in death of mature T cells in vivo is still controversial. Here we show that triggering of the costimulatory TNF receptor family member CD27 sensitized T cells for CD95-induced apoptosis. CD95-deficient (lpr/lpr) T cells massively expanded and differentiated into IFN-gamma-secreting effector cells in transgenic mice that constitutively express the CD27 ligand, CD70. Concomitantly, CD95-deficient CD70 transgenic mice became moribund by 4 wk of age with severe liver pathology and bone marrow failure. These findings establish that CD95 is a critical regulator of effector T cell homeostasis in chronic immune activation.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom